特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

幹細胞の世界市場:成長率、動向および予測(2020年~2025年)

Stem Cell Market - Growth, Trends, and Forecasts (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 390704
出版日 ページ情報 英文 112 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=106.59円で換算しております。
幹細胞の世界市場:成長率、動向および予測(2020年~2025年) Stem Cell Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日: 2020年06月01日 ページ情報: 英文 112 Pages
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
概要

世界中で臨床試験が増えているため、幹細胞市場は成長しています。北米地域、特に米国は、幹細胞療法を受ける試験数で優位に立ちました。米国は、製品およびバンキングサービスの両セグメントにおいて市場を支配しており、北米市場全体の約77.4%を占めています。それに対して、アジア太平洋地域は最も高い成長率で成長しています。幹細胞は再生医療、特に皮膚科の分野で主に使用されています。また、腫瘍学は、腫瘍または癌の治療のために存在する多数のパイプライン製品によって、最高の成長率で成長すると予想されています。再生医療センターの増加に伴い、幹細胞市場も将来的に拡大すると予想されています。

当レポートでは、世界の幹細胞市場を調査し、全体的な市場動向、製品タイプ・治療用途・治療タイプ・バンキングサービス・技術およびバンキングタイプ・地域別の詳細動向、市場成長への影響要因の分析、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

目次

1 イントロダクション

  • 調査の成果
  • 調査の前提条件
  • 調査範囲

2 調査方法

3 エグゼクティブサマリー

4 市場のダイナミクス

  • 市場概況
  • 市場成長要因
    • 臍帯幹細胞についての意識の高まり
    • 幹細胞研究における臨床試験の承認の増加
    • 再生治療の選択肢に対する需要の高まり
    • 慢性疾患に対する治療選択肢を開発するための研究開発イニシアチブの高まり
  • 市場阻害要因
    • 高額な治療
    • 規制上の問題
    • 倫理的および道徳的枠組み
  • 業界の魅力 - ポーターのファイブフォース分析
    • 新規参入者の脅威
    • 買い手/消費者の交渉力
    • 売り手の交渉力
    • 代替製品の脅威
    • 業界内の競合の激しさ

5 市場セグメンテーション

  • 製品タイプ別
    • 成人幹細胞
    • ヒト胚細胞
    • 多能性幹細胞
    • 他の製品タイプ
  • 治療用途別
    • 神経学的障害
    • 整形外科治療
    • 腫瘍疾患
    • 糖尿病
    • 怪我と傷
    • 心血管障害
    • その他の治療用途
  • 治療タイプ別
    • 同種幹細胞療法
    • オートロジック幹細胞療法
    • 同系幹細胞療法
  • バンキングサービスおよび技術別
    • 幹細胞の取得と検査
    • 細胞生成
    • 拡張
    • 二次培養
    • 凍結保存
  • バンキングタイプ別
    • 公的
    • 民間
  • 地理
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

6 競合情勢

  • 企業プロファイル
    • Osiris Therapeutics Inc.
    • Pluristem Therapeutics Inc.
    • Thermo Fisher Scientific
    • Qiagen NV
    • Sigma Aldrich Corporation
    • Becton, Dickinson and Company
    • Stem Cell Technologies Inc.
    • AllCells LLC
    • Miltenyi Biotec
    • International Stem Cell Corporation

7 市場機会および将来動向

目次
Product Code: 47511

The stem cell market is experiencing growth, owing to the increasing number of clinical trials around the world. North America, especially the United States, dominated the number of trials undergoing stem cell therapies. However, Asia-Pacific is growing at the highest growth rate. Stem cells are majorly used in regenerative medicine, especially in the field of dermatology. However, oncology is expected to grow at the highest growth rate, due to a large number of pipeline products present for the treatment of tumors or cancers. With the increase in the number of regenerative medicine centers, the stem cell market is also expected to increase in the future.

Stem cell banking is gaining importance with the support of government initiatives. The number of stem cell banks is increasing in developing countries, which is aiding the growth of the market. Also, increasing awareness about stem cell storage among the people has positively affected the market. Currently, the market is not well established in many therapeutic areas and has shown nascent success in history. However, it holds great potential in both the diagnosis and therapeutic fields.

Key Market Trends

Oncology Disorders Segment is Expected to Exhibit Fastest Growth Rate Over the Forecast Period

Cancer has a major impact on the world. According to the World Health Organization (WHO) 2018 data on cancer, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018. Moreover, Cancer Research UK suggests that the population suffering from cancer is expected to increase in the future. As per the report, if recent trends in the incidence of major cancers and population growth are consistent, it is predicted there will be 27.5 million new cancer cases worldwide each year by 2040.

Stem cell transplants are procedures that restore blood-forming stem cells in people who have had theirs destroyed by the very high doses of chemotherapy or radiation therapy. Embryonic stem cells (ESC) are the major source of stem cells for therapeutic purposes, due to their higher totipotency and indefinite lifespan, as compared to adult stem cells with lower totipotency and restricted lifespan. These advantages along with the increasing incidence of cancer is expected to help the growth of stem cell market

North America Captured The Largest Market Share and is Expected to Retain its Dominance

North America dominated the overall stem cell market with the United States contributing to the largest share in the market. The United States (US) and Canada have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the US and Canada. As a result, these countries enjoy the presence of many global market players. Additionally, Mexico is a developing nation with the benefit of being a neighbor to the United States. This allows many companies to penetrate in Mexico as well. This helps the growth in the region.

Competitive Landscape

The stem cell market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. The presence of major market players, such as Thermo Fisher Scientific (Qiagen NV), Sigma Aldrich (A Subsidiary of Merck KGaA), Becton, Dickinson and Company, and Stem Cell Technologies, is in turn, increasing the overall competitive rivalry in the market. The product advancements and improvement in stem cell technology by the major players are increasing the competitive rivalry.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increased Awareness about Umbilical Stem Cell
    • 4.2.2 Rising R&D Initiatives to Develop Stem Cell Therapies and Increasing Approvals for Clinical Trials in Stem Cell Research
    • 4.2.3 Growing Demand for Regenerative Treatment Option
  • 4.3 Market Restraints
    • 4.3.1 Expensive Procedures
    • 4.3.2 Regulatory Complications
    • 4.3.3 Ethical and Moral Framework
  • 4.4 Industry Attractiveness- Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product Type
    • 5.1.1 Adult Stem Cell
    • 5.1.2 Human Embryonic Cell
    • 5.1.3 Pluripotent Stem Cell
    • 5.1.4 Other Product Types
  • 5.2 By Application
    • 5.2.1 Neurological Disorders
    • 5.2.2 Orthopedic Treatments
    • 5.2.3 Oncology Disorders
    • 5.2.4 Injuries and Wounds
    • 5.2.5 Cardiovascular Disorders
    • 5.2.6 Other Applications
  • 5.3 By Treatment Type
    • 5.3.1 Allogeneic Stem Cell Therapy
    • 5.3.2 Auto logic Stem Cell Therapy
    • 5.3.3 Syngeneic Stem Cell Therapy
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 United Kingdom
      • 5.4.2.2 Germany
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East & Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East & Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Osiris Therapeutics Inc.
    • 6.1.2 PLURISTEM THERAPEUTICS INC.
    • 6.1.3 Thermo Fisher Scientific
    • 6.1.4 Merck KGaA (Sigma Aldrich)
    • 6.1.5 Becton, Dickinson and Company
    • 6.1.6 Stem Cell Technologies Inc.
    • 6.1.7 AllCells LLC
    • 6.1.8 Miltenyi Biotec
    • 6.1.9 International Stem Cell Corporation
    • 6.1.10 Smith & Nephew PLC

7 MARKET OPPORTUNITIES AND FUTURE TRENDS